anticompetitive

Pfizer Will Pay $50M to Settle EpiPen Antitrust Claims

Dave Bloom - 2023/10/17

Who won? Not you.

Who Benefits Most from Pfizer’s $345M EpiPen Price Gouging Settlement? Not...

Dave Bloom - 2021/11/18

One-third of the total award will go to the law firms that represented consumers in the suit.

Sanofi Seeking Billions from Mylan in EpiPen Antitrust Suit

Dave Bloom - 2019/08/13

Sordid details of anticompetitive behavior alleged in court filing.

Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.

We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.

Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.

Please see our Terms of service and Privacy Policy.

SnackSafely.com, PO Box 141, Hillsdale, NJ 07642

Tag: anticompetitive

Pfizer Will Pay $50M to Settle EpiPen Antitrust Claims

Who Benefits Most from Pfizer’s $345M EpiPen Price Gouging Settlement? Not...

Sanofi Seeking Billions from Mylan in EpiPen Antitrust Suit